BRÈVE

sur Moderna, Inc. (NASDAQ:MRNA)

Moderna to Participate in March 2025 Investor Conferences

Graphique de l'évolution du cours de l'action Moderna, Inc. (EBR:MRNA).

Moderna, Inc. has announced its upcoming participation in two significant investor conferences scheduled for March 2025. The company will present at the TD Cowen 45th Annual Health Care Conference on March 5th at 9:10am ET and the Barclays 27th Annual Global Healthcare Conference on March 11th at 1:30pm ET.

Both presentations will be accessible to the public via live webcasts, available under the "Events and Presentations" section in the Investors area on Moderna's website. The webcasts will be archived for a minimum of 30 days for later viewing.

These appearances reflect Moderna's ongoing engagement with the investor community and provide an opportunity to share insights into their mRNA technology advancements. Moderna remains at the forefront of mRNA medicine, with a focus on developing innovative treatments and vaccines.

R. E.

Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Moderna, Inc.